Published in J Clin Invest on March 01, 1995
Functional beta3-adrenoceptor in the human heart. J Clin Invest (1996) 2.32
The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium. Br J Pharmacol (2003) 0.94
β(3) Receptors: Role in Cardiometabolic Disorders. Ther Adv Endocrinol Metab (2011) 0.79
Comparative effects of oleoyl-estrone and a specific beta3-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue. Nutr Metab (Lond) (2010) 0.75
Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature (1994) 7.86
Molecular characterization of the human beta 3-adrenergic receptor. Science (1989) 4.13
Beta 3 and atypical beta-adrenoceptors. Med Res Rev (1993) 2.21
The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci (1994) 1.76
A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest (1995) 1.30
Obesity and insulin resistance. J Clin Invest (2000) 10.47
Obesity and the regulation of energy balance. Cell (2001) 9.48
Role of leptin in the neuroendocrine response to fasting. Nature (1996) 8.02
Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature (1994) 7.86
A transgenic model of visceral obesity and the metabolic syndrome. Science (2001) 6.22
Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med (1995) 5.45
Adipogenesis and obesity: rounding out the big picture. Cell (1996) 5.15
Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell (2001) 5.13
The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med (1976) 5.09
Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest (1998) 4.85
Leptin. Annu Rev Physiol (2000) 4.78
Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell (2001) 4.58
Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol (1998) 4.30
Adipose tissue as an endocrine organ. Trends Endocrinol Metab (2000) 4.07
Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell (1998) 3.84
Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med (1991) 3.58
Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med (2000) 3.53
Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest (2000) 3.50
Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science (1987) 3.44
Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature (1998) 3.38
Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron (1999) 3.37
Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest (1995) 3.18
Direct demonstration that receptor crosslinking or aggregation is important in insulin action. Proc Natl Acad Sci U S A (1978) 3.15
Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem (1997) 3.01
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest (1996) 2.98
Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science (1975) 2.97
Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med (1997) 2.73
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest (1997) 2.73
Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem (2000) 2.65
The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem (1999) 2.63
Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med (1997) 2.48
SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem (2000) 2.41
Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem (1995) 2.27
Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest (1998) 2.23
Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest (1999) 2.22
beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem (1999) 2.13
Leptin regulation of neuroendocrine systems. Front Neuroendocrinol (2000) 2.12
Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci (1998) 2.08
Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes (2000) 2.06
UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun (1997) 2.06
Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest (2001) 2.05
Severely impaired adipsin expression in genetic and acquired obesity. Science (1987) 2.03
Brown adipose tissue, beta 3-adrenergic receptors, and obesity. Annu Rev Med (1997) 2.03
Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology (1996) 1.99
Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem (2000) 1.99
Leptin, nutrition, and reproduction: timing is everything. J Clin Endocrinol Metab (2000) 1.98
Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci U S A (1986) 1.94
Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man. J Clin Invest (1987) 1.93
Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes (1990) 1.93
Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci U S A (1998) 1.92
Differential regulation of two glucose transporters in adipose cells from diabetic and insulin-treated diabetic rats. J Clin Invest (1989) 1.89
Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology (1999) 1.87
Characterization of the insulin resistance of aging. J Clin Invest (1983) 1.83
Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology (1999) 1.81
Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology (1997) 1.81
Leptin accelerates the onset of puberty in normal female mice. J Clin Invest (1997) 1.80
Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science (1987) 1.77
Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol (1989) 1.77
Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology (1997) 1.75
Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man. J Clin Invest (1976) 1.74
Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem (1992) 1.74
Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest (2001) 1.72
Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. J Biol Chem (1997) 1.69
Insulin receptors, receptor antibodies, and the mechanism of insulin action. Recent Prog Horm Res (1981) 1.68
Reduced activity of the red-cell sodium-potassium pump in human obesity. N Engl J Med (1980) 1.68
Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J (1986) 1.66
In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology (2000) 1.66
Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology (1997) 1.64
Functional properties of leptin receptor isoforms containing the gln-->pro extracellular domain mutation of the fatty rat. Endocrinology (1998) 1.62
Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem (1997) 1.53
Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes (1996) 1.53
In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism. J Biol Chem (2001) 1.49
A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab (1997) 1.42
Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter. J Biol Chem (1997) 1.42
Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. Hum Mol Genet (1998) 1.40
Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. Proc Natl Acad Sci U S A (1998) 1.39
Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc Natl Acad Sci U S A (2000) 1.39
Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways. J Biol Chem (2000) 1.39
Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab (2001) 1.38
Expression of leptin receptor isoforms in rat brain microvessels. Endocrinology (1998) 1.36
Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab (2000) 1.33
Normal insulin-receptor cDNA sequence in Pima Indians with NIDDM. Diabetes (1989) 1.31
Receptors, antireceptor antibodies and mechanisms of insulin resistance. N Engl J Med (1979) 1.29
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem (1996) 1.28
Role of the beta(3)-adrenergic receptor and/or a putative beta(4)-adrenergic receptor on the expression of uncoupling proteins and peroxisome proliferator-activated receptor-gamma coactivator-1. Biochem Biophys Res Commun (1999) 1.27
Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. J Clin Endocrinol Metab (1997) 1.26
Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation. Diabetes (1999) 1.26
Defect in insulin receptor phosphorylation in erythrocytes and fibroblasts associated with severe insulin resistance. J Biol Chem (1984) 1.24
Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. J Clin Endocrinol Metab (1994) 1.24
Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem (1996) 1.24